Xiao Nan, Qu Jialin, He Shiyong, Huang Peng, Qiao Yanling, Li Guangxing, Pan Taowen, Sui Hua, Zhang Lin
Institute of Integrative Medicine, Dalian Medical University, Dalian, China.
Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Front Pharmacol. 2020 Jan 31;10:1626. doi: 10.3389/fphar.2019.01626. eCollection 2019.
Gouty arthritis is a common metabolic disease caused by long-term purine metabolic disorder and elevated serum uric acid. Jiang-Suan-Chu-Bi recipe (JSCBR), a traditional Chinese herbal formula prescribed according to utilization frequency and cluster analysis, has been clinically validated remedy for gouty arthritis. However, its therapeutic composition and mechanism remains unclear.
In the present study, a simple, rapid, and sensitive ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS)-based chemical profiling was firstly established for comprehensively identifying the major constituents in JSCBR. A phytochemistry-based network pharmacology analysis was further performed to explore the potential therapeutic targets and pathways involved in JSCBR bioactivity. Finally, THP-1 cell model was used to verify the prediction results of network pharmacology by western blot analysis.
A total of 139 compounds containing phenolic acids, flavonoids, triterpenoid saponins, alkaloids, amino acids, fatty acids, anthraquinones, terpenes, coumarins, and other miscellaneous compounds were identified, respectively. 175 disease genes, 51 potential target nodes, 80 compounds, and 11 related pathways based on network pharmacology analysis were achieved. Among these pathways and genes, NOD-like receptor signaling pathway may play an important role in the curative effect of JSCBR on gouty arthritis by regulation of NRLP3/ASC/CASP1/IL1B. The results of cellular and molecular experiments showed that JSCBR can effectively reduce the protein expression of ASC, caspase-1, IL-1β, and NRLP3 in monosodium urate-induced THP-1 cells, which indicated that JSCBR mediated inflammation in gouty arthritis by inhibiting the activation of NOD-like receptor signaling pathway.
Thus, the integrated approaches adopted in the present study could contribute to simplifying the complex system and providing directions for further research of JSCBR.
痛风性关节炎是一种由长期嘌呤代谢紊乱和血清尿酸升高引起的常见代谢性疾病。降酸除痹方(JSCBR)是根据使用频率和聚类分析开出的一种中药方剂,已被临床验证为治疗痛风性关节炎的有效药物。然而,其治疗成分和机制仍不清楚。
在本研究中,首先建立了一种基于超高效液相色谱-四极杆飞行时间质谱(UHPLC-QTOF-MS)的简单、快速、灵敏的化学图谱分析方法,用于全面鉴定JSCBR中的主要成分。进一步进行基于植物化学的网络药理学分析,以探索JSCBR生物活性涉及的潜在治疗靶点和途径。最后,利用THP-1细胞模型通过蛋白质印迹分析验证网络药理学的预测结果。
共鉴定出139种化合物,分别为酚酸、黄酮类、三萜皂苷、生物碱、氨基酸、脂肪酸、蒽醌、萜类、香豆素和其他杂类化合物。基于网络药理学分析,获得了175个疾病基因、51个潜在靶点节点、80种化合物和11条相关途径。在这些途径和基因中,NOD样受体信号通路可能通过调节NRLP3/ASC/CASP1/IL1B在JSCBR治疗痛风性关节炎的疗效中发挥重要作用。细胞和分子实验结果表明,JSCBR能有效降低尿酸钠诱导的THP-1细胞中ASC、caspase-1、IL-1β和NRLP3的蛋白表达,这表明JSCBR通过抑制NOD样受体信号通路的激活介导痛风性关节炎中的炎症反应。
因此,本研究采用的综合方法有助于简化复杂系统,并为JSCBR的进一步研究提供方向。